Overview We are seeking an Associate Director of Quantitative Modeling to lead and execute advanced modeling and simulation strategies supporting drug development across early and late-stage programs. This individual will play a critical role in informing
Location: Zurich - remote, hybrid or relocation. Have you ever wanted to take full ownership of a drug discovery programme, from initial idea through to first in human? This is an opportunity to join a venture-backed,
Associate Director, Medical Writing Location: Hybrid 4 days/week in South San Francisco, CA (2 remote flex days per month!) Relocation Assistance Available About the Opportunity Our client is seeking an experienced Associate Director, Medical Writing to
Vice President, Regulatory Affairs – Permanent – San Francisco, CA Proclinical is seeking a Vice President, Regulatory Affairs for a rapidly growing and exciting clinical-stage biotechnology company based in the San Francisco Bay Area, California. Primary
Our On-Demand Talent Solutions team is partnering with our trusted client to identify a Director-level Clinical Scientist. Our client is a biopharmaceutical company developing next-generation targeted therapies for cancer. This role is ideal for a drug
Associate Director, Medical Writing (Hybrid - SF Bay Area) We are seeking an experienced Associate Director of Medical Writing to lead the development of high-quality clinical and regulatory documents in support of complex drug development programs.
Kelly® Science & Clinical is seeking an Associate Director, Nonclinical Study Management for a direct hire opportunity with one of our clients, a precision immunology bio-therapeutics company focused on the development of disruptive therapies for the
A well-funded, clinical stage biotechnology company at the forefront of targeted protein degradation is seeking a Vice President of Translational Medicine & Clinical Biomarkers to lead enterprise-wide translational strategy across a growing oncology and immunology pipeline.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company